Device
Spirotiger®
Spirotiger® is a medical device with 3 clinical trials. Historical success rate of 100.0%.
Total Trials
3
Max Phase
—
Type
DEVICE
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 2 completed trials
Completion Rate
100%(2/2)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Phase Distribution
Ph not_applicable
3
100%
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution3 total trials
N/ANon-phased studies
3(100.0%)
Highest Phase Reached
UnknownTrial Status & Enrollment
Completion Rate
100.0%
2 of 2 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
3
all time
Status Distribution
Completed(2)
Other(1)
Detailed Status
Completed2
unknown1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
0
Success Rate
100.0%
Most Advanced
N/A
Trials by Phase
N/A3 (100.0%)
Trials by Status
completed267%
unknown133%
Recent Activity
0 active trials
Showing 3 of 3
completednot_applicable
Effectiveness of Respiratory Muscle Training by Spirotiger in Chronic Patients
NCT01556139
unknownnot_applicable
Inspiratory Muscle Training With Normocapnic Hyperpnea in Chronic Obstructive Pulmonary Disease (COPD)
NCT01218295
completednot_applicable
Respiratory Muscle Training in Obstructive Sleep Apnea Syndrome (OSAS) Patients
NCT00936286
Clinical Trials (3)
Showing 3 of 3 trials
NCT01556139Not Applicable
Effectiveness of Respiratory Muscle Training by Spirotiger in Chronic Patients
NCT01218295Not Applicable
Inspiratory Muscle Training With Normocapnic Hyperpnea in Chronic Obstructive Pulmonary Disease (COPD)
NCT00936286Not Applicable
Respiratory Muscle Training in Obstructive Sleep Apnea Syndrome (OSAS) Patients
All 3 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 3